Advanced Biomed Inc.
ADVB
$1.76
-$0.14-7.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 282.30K | 338.30K | 463.70K | 463.70K | 462.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 525.70K | 520.00K | 725.00K | 725.00K | 651.30K |
| Operating Income | -525.70K | -520.00K | -725.00K | -725.00K | -651.30K |
| Income Before Tax | -907.90K | -265.60K | -932.80K | -932.80K | -145.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -907.90K | -265.60K | -932.80K | -932.80K | -145.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -907.90K | -265.60K | -932.80K | -932.80K | -145.30K |
| EBIT | -525.70K | -520.00K | -725.00K | -725.00K | -651.30K |
| EBITDA | -426.70K | -417.80K | -672.20K | -672.20K | -577.90K |
| EPS Basic | -0.05 | -0.01 | -0.05 | -0.05 | -0.01 |
| Normalized Basic EPS | -0.03 | -0.01 | -0.03 | -0.03 | 0.00 |
| EPS Diluted | -0.05 | -0.01 | -0.05 | -0.05 | -0.01 |
| Normalized Diluted EPS | -0.03 | -0.01 | -0.03 | -0.03 | 0.00 |
| Average Basic Shares Outstanding | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M |
| Average Diluted Shares Outstanding | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |